Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / Peptides / Research peptides vs prescription peptide therapy
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Written by Dr. Parmis Mojarab, DO·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Methodology v1.0

Research peptides vs prescription peptide therapy

Quick answer

Research peptides are unapproved products sold without medical oversight or quality assurance. Prescription peptide therapy involves a licensed clinician, a licensed pharmacy, and — for approved products — FDA oversight. The safety gap between them is large.

'Research' peptides

Sold online as chemicals, no clinician, no pharmacy oversight, no quality verification, and unlawful for human use.

Prescription therapy

Clinician-directed, pharmacy-dispensed, and — where the peptide is an approved drug like tesamorelin — FDA-regulated. This is the only pathway we cover as legitimate.

Frequently asked questions

What's the difference between research and prescription peptides?

Prescription therapy has clinician oversight, pharmacy dispensing and (for approved drugs) FDA regulation. Research peptides have none of these and are unlawful for human use.

Sources

  1. U.S. Food and Drug Administration — labels and safety communications.
  2. Peer-reviewed clinical trials cited above.
  3. Our methodology and medical review policy.

Spotted an error? Submit a correction.